Detalhe da pesquisa
1.
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biol Blood Marrow Transplant
; 17(6): 867-74, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868761
2.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167680
3.
Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Leuk Lymphoma
; 60(3): 639-648, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30160568
4.
Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.
Am J Hematol
; 86(9): 792-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21805495
5.
Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
Cytometry B Clin Cytom
; 82(5): 283-94, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508650
6.
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).
Leuk Lymphoma
; 52(1): 34-41, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21133716
7.
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Biol Blood Marrow Transplant
; 13(8): 925-31, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17640596
8.
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
Biol Blood Marrow Transplant
; 12(4): 480-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16545732
9.
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Biol Blood Marrow Transplant
; 8(8): 435-43, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12234169